Diagnostic Use of Genome Sequencing in Patients With 11p15.5 Imprinting Disorder Features: A Pilot Study
Clinical Genetics · 2025
DOI: 10.1111/cge.14649 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, 2025. Verfasst von Luise Kessler und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Human Genetics and Genomic Medicine, Medical Faculty, RWTH Aachen University, Aachen, Germany. Hauptthemen laut MEDLINE: Genomic Imprinting, Beckwith-Wiedemann Syndrome, Silver-Russell Syndrome, Chromosomes, Human, Pair 11. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Illumina.
Abstract (Originalsprache)
To assess the suitability of genome sequencing (GS) as the second step in the diagnostics of patients with the features of 11p15.5‐associated imprinting disorders (ImpDis: Silver–Russell syndrome [SRS], Beckwith–Wiedemann syndrome [BWS]), we performed short‐read GS in patients negatively tested for imprinting disturbances. Obtaining a genetic diagnosis for patients with the features of these syndromes is challenging due to the clinical and molecular heterogeneity and overlap, and many patients remain undiagnosed after the currently suggested stepwise diagnostic workup. GS was conducted in 48 patients (SRS features: n = 37 and BWS features: n = 11). The detection rate differed markedly between the ImpDis: although a genetic cause could be identified in 51% of patients referred with SRS features, no pathogenic variants were detected in patients with BWS features. Thus, GS substantially improves the diagnostic yield and broadens the spectrum of overlapping disorders with SRS features. Obtaining a precise molecular diagnosis provides the basis for a personalized clinical management. Our findings support the use of GS as a second‐tier diagnostic tool for patients with growth disturbances, as it addresses all currently known variant types and shortens the diagnostic odyssey.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Human Genetics and Genomic Medicine, Medical Faculty, RWTH Aachen University, Aachen, Germany.
- Department of Human Genetics, Medical Research Institute, Alexandria University, Alexandria, Egypt.
- 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary.
ORCID-Profile: Luise Kessler, Jeremias Krause, Florian Kraft, Asmaa K Amin, Gyorgy Fekete, Anna Lengyel, Eva Pinti, Arpad Kovacs, Annette Lischka, Katja Eggermann, Ingo Kurth, Cordula Knopp, Miriam Elbracht, Matthias Begemann, Thomas Eggermann
Förderung
- Deutsche Forschungsgemeinschaft
- Illumina
Zitieren
APA
Kessler, L., Krause, J., Kraft, F., Amin, A. K., Fekete, G., Lengyel, A., Pinti, E., Kovacs, A., Lischka, A., Eggermann, K., Kurth, I., Knopp, C., Elbracht, M., Begemann, M., & Eggermann, T. (2025). Diagnostic Use of Genome Sequencing in Patients With 11p15.5 Imprinting Disorder Features: A Pilot Study. Clinical Genetics. https://doi.org/10.1111/cge.14649
Vancouver
Kessler L, Krause J, Kraft F, Amin AK, Fekete G, Lengyel A, et al. Diagnostic Use of Genome Sequencing in Patients With 11p15.5 Imprinting Disorder Features: A Pilot Study. Clinical Genetics. 2025. doi:10.1111/cge.14649
BibTeX
@article{Kessler2025,
author = {Kessler, Luise and Krause, Jeremias and Kraft, Florian and Amin, Asmaa K and Fekete, Gyorgy and Lengyel, Anna and Pinti, Eva and Kovacs, Arpad and Lischka, Annette and Eggermann, Katja and Kurth, Ingo and Knopp, Cordula and Elbracht, Miriam and Begemann, Matthias and Eggermann, Thomas},
title = {Diagnostic Use of Genome Sequencing in Patients With 11p15.5 Imprinting Disorder Features: A Pilot Study},
journal = {Clinical Genetics},
year = {2025},
doi = {10.1111/cge.14649}
}
EUVIMED